Evolocumab for prevention of microvascular dysfunction in patients undergoing percutaneous coronary intervention: the randomised, open-label EVOCATION trial.
暂无分享，去创建一个
M. Asakura | K. Tsujita | S. Suwa | M. Ishihara | Yasuo Okumura | K. Fujii | K. Hibi | H. Takano | S. Suna | T. Mano | W. Shimizu | K. Okada | M. Igeta | Rika Okamoto | Shinichiro Suna